跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.172) 您好!臺灣時間:2025/09/11 13:54
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:潘璿帆
研究生(外文):Hsuan-Fan Pan
論文名稱:石蓴萃取物抑制黃質病毒感染機轉之研究
論文名稱(外文):Study of inhibitory effects of flavivirus infection by the extracts of the Ulva lactuca
指導教授:廖經倫吳彰哲
指導教授(外文):Ching-Len LiaoChang-Jer Wu
學位類別:碩士
校院名稱:國立臺灣海洋大學
系所名稱:食品科學系
學門:農業科學學門
學類:食品科學類
論文種類:學術論文
論文出版年:2007
畢業學年度:95
語文別:中文
論文頁數:61
中文關鍵詞:石蓴黃質病毒登革病毒日本腦炎病毒
外文關鍵詞:Ulva lactucaflavivirusDENJEV
相關次數:
  • 被引用被引用:1
  • 點閱點閱:244
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
近年來藉由節肢動物 (Arthropod)所傳播的黃質病毒感染病例有逐年升高的趨勢,且登革病毒和日本腦炎病毒等黃質病毒散佈的範圍很廣。登革熱和登革出血熱是因為登革病毒感染所引起的,目前仍是世界性的公共衛生問題。海藻中已知的成分-硫酸多醣(sulfated polysaccharides),其生理活性被廣泛的應用於抗病毒、抗腫瘤、抗氧化、抗凝血劑、降膽固醇等療效。本研究主要是以細胞培養的方式,探討由綠藻屬之石蓴(Ulva lactuca)的三種水溶萃取物A1、A4及A8,是否能有效抑制黃質病毒感染細胞。100 µg/ml的三種石蓴萃取物並無細胞毒性;以間接免疫螢光法觀察,100 µg/ml之A4或A8對DEN2感染BHK-21細胞之抑制率約九成,而對HepG2細胞的感染亦有明顯的抑制。進一步研究發現石蓴萃取物抑制DEN2之作用機制是在病毒感染的初期,可能是抑制病毒與細胞之間的吸附及/或穿透步驟。另外,該萃取物對同屬於黃質病毒的JEV感染亦具抑制效果,但是其卻對α病毒屬(Alphavirus)的Sindbis virus感染BHK-21細胞無抑制作用(即使在250 µg/ml和500 µg/ml的高濃度下)。由以上結果顯示,某些石蓴水溶萃取物具有專一制黃質病毒感染之能力,而此能力是否與其所含硫酸多醣的種類及含量有關值得進一步研究。
Viral infectious diseases caused by arthropod-borne flaviviruses have been gradually increased worldwide in recent years, especially including dengue virus (DEN) and Japanese encephalitis virus (JEV) prevalent in Taiwan and other South Asia countries. Dengue viruses cause dengue fever and dengue related diseases that represent a global public health problem. Seaweeds have known to possess an ingredient of sulfated polysaccharides that have been widely used as curative agents for anti-virus, anti-tumor, anti-oxidation, anti-coagulant, and control of normal cholesterol levels. The main purpose of this thesis is to study, by using cell cultures, the anti-DEN effect of the water-soluble extracts from Ulva lactuca, which belongs to green seaweed. Three homogeneous extracts of Ulva lactuca leaves, A1, A4 and A8, were used in this study and we found them had no cytotoxicity to the cultured cells at as high as 100 µg/ml. By indirect immunofluorescence assay, we observed that 100 µg/ml of A4 or A8 could suppress DEN infection to BHK-21 cells by 90%, and similarly we found they could also inhibit DEN infection to human hepatocyte HepG2 cells. We further noticed that these extracts were active against DEN infection only during the early stage of virus adsorption and penetration. Moreover, another flavivirus JEV was also found to be blocked to certain degrees by Ulva lactuca extracts when infected to BHK-21 cells. However, Sindbis virus, a member of Alphaviruses, appeared to be not suppressed by these extracts even their concentrations were used as high as 500 µg/ml. Together, our results demonstrate that the extracts from green seaweed Ulva lactuca, comprising abundant sulfated polysaccharides, have a specific anti-flavivirus effect in cultured system and the medical values of these extracts are worth further studying.
目 錄
中文摘要........Ⅰ
Abstract........Ⅱ
目錄............Ⅲ
圖表目錄........Ⅴ
壹、前言........1
貳、文獻回顧....3
一、黃質病毒之簡介....3
二、黃質病毒基因結構 (Genome structure).....3
三、黃質病毒傳染途徑......4
四、海藻的成分及其生理活性.....6
參、實驗設計......8
肆、材料與方法....9
一、材料......9
(一)原料......9
(二)實驗所使用之細胞株....9
(三)實驗所使用之病毒株....9
(四)實驗所使用之抗體......9
(五)化學藥品與試劑.......10

二、實驗方法......10
(一)細胞株培養....10
(二)細胞存活率之分析 (XTT assay)....11
(三)DEN2之增殖....11
(四)JEV RP9之增殖...12
(五)病毒效價之測定(Virus titration).....12
(六)病毒感染(Virus infection).....13
(七)間接免疫螢光染色法(Indirect immunofluoresent assay)...13

伍、結果........15
一、石蓴萃取物對培養細胞之毒性..........15
二、石蓴萃取物對DEN2感染BHK-21細胞之影響......15
三、石蓴萃取物對不同宿主細胞感染DEN2後之影響....18
四、石蓴萃取物在不同時間點處理下對DEN2感染之影響....20
五、石蓴萃取物對病毒感染細胞初期之影響......21
六、石蓴萃取物對其他RNA病毒感染BHK-21細胞之影響....22
陸、討論....24
參考文獻....29
圖表........33
附錄........61

圖 表 目 錄
圖一、石蓴萃取物對BHK-21細胞毒性之影響......33
圖二、石蓴萃取物A1在不同濃度下於BHK-21細胞對DEN2感染後
24小時之影響......34
圖三、石蓴萃取物A4在不同濃度下於BHK-21細胞對DEN2感染後
24小時之影響......35
圖四、石蓴萃取物A8在不同濃度下於BHK-21細胞對DEN2感染後
24小時之影響......36
圖五、石蓴萃取物A1在不同濃度下於BHK-21細胞對DEN2感染後
48小時之影響......37
圖六、石蓴萃取物A4在不同濃度下於BHK-21細胞對DEN2感染後
48小時之影響......38
圖七、石蓴萃取物A8在不同濃度下於BHK-21細胞對DEN2感染後
48小時之影響......39
圖八、石蓴萃取物A1在不同濃度下於BHK-21細胞對DEN2感染後
72小時之影響......40
圖九、石蓴萃取物A4在不同濃度下於BHK-21細胞對DEN2感染後
72小時之影響......41
圖十、石蓴萃取物 A8在不同濃度下於BHK-21細胞對DEN2感染後
72小時之影響......42
圖十一、石蓴萃取物A4和A8於BHK-21細胞對DEN2感染24小時後以
plaque assay分析病毒效價......43
圖十二、石蓴萃取物於BHK-21細胞感染DEN2後24小時之影響....44
圖十三、石蓴萃取物對HepG2細胞毒性之影響......45
圖十四、石蓴萃取物A1在不同濃度下於HepG2 細胞對DEN2感染
後48小時之影響.......46
圖十五、石蓴萃取物A4在不同濃度下於HepG2細胞對DEN2感染
後48小時之影響.......47
圖十六、石蓴萃取物A8在不同濃度下於HepG2細胞對DEN2感染
後48小時之影響.......48
圖十七、在DEN2 感染前先加入石蓴萃取物A4對BHK-21細胞之影響......49
圖十八、在DEN2 感染的同時加入石蓴萃取物A4 對BHK-21細胞之影響......50
圖十九、在DEN2感染後加入石蓴萃取物A4對BHK-21細胞之影響......51
圖二十、在DEN2感染前先加入石蓴萃取物A8對BHK-21細胞之影響......52
圖二十一、在DEN2 感染的同時加入石蓴萃取物A8對BHK-21細胞之影響......53
圖二十二、在DEN2 感染後加入石蓴萃取物A8對BHK-21細胞之影響......54
圖二十三、石蓴萃取物A4對DEN2感染BHK-21細胞吸附之影響......55
圖二十四、石蓴萃取物A8對DEN2感染BHK-21細胞吸附之影響......56
圖二十五、石蓴萃取物A4對JEV感染BHK-21細胞之影響...........57
圖二十六、石蓴萃取物A8對JEV感染BHK-21細胞之影響...........58
圖二十七、石蓴萃取物對Sindbis感染BHK-21細胞之影響.........59
圖二十八、石蓴萃取物對Sindbis感染BHK-21細胞之影響.........60
附錄一 綠藻屬之石蓴(Ulva lactuca) 萃取物之萃取條件及成分..61
參考文獻
Buck, C. B., Thompson, C. D., Roberts, J. N., Muller, M., Lowy, D. R., and Schiller, J. T. (2006). Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2(7), e69.
Burke, D. S., and Monath, T. P. (2001). Flaviviruses. 4th ed. In "Fields Virology" (D. M. Knipe, and P. M. Howley, Eds.), Vol. 1, pp. 1043-1125. Lippincott-Williams & Wilkins, Philadelphia, Pa., USA.
Byrnes, A. P., and Griffin, D. E. (1998). Binding of Sindbis virus to cell surface heparan sulfate. J Virol 72(9), 7349-56.
Chambers, T. J., Hahn, C. S., Galler, R., and Rice, C. M. (1990). Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44, 649-88.
Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., and Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8), 866-71.
Clapham, P. R., and McKnight, A. (2002). Cell surface receptors, virus entry and tropism of primate lentiviruses. J Gen Virol 83(Pt 8), 1809-29.
Couvelard, A., Marianneau, P., Bedel, C., Drouet, M. T., Vachon, F., Henin, D., and Deubel, V. (1999). Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 30(9), 1106-10.
Damonte, E. B., Matulewicz, M. C., and Cerezo, A. S. (2004). Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem 11(18), 2399-419.
Germi, R., Crance, J. M., Garin, D., Guimet, J., Lortat-Jacob, H., Ruigrok, R. W., Zarski, J. P., and Drouet, E. (2002). Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292(1), 162-8.
Gregson, A., and Edelman, R. (2003). Dengue virus infection. Pediatr Infect Dis J 22(2), 179-81.
Gubler, D. J. (2002). Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10(2), 100-3.
Itoh, H., Noda, H., Amano, H., Zhuaug, C., Mizuno, T., and Ito, H. (1993). Antitumor activity and immunological properties of marine algal polysaccharides, especially fucoidan, prepared from Sargassum thunbergii of Phaeophyceae. Anticancer Res 13(6A), 2045-52.
Kuno, G., Chang, G. J., Tsuchiya, K. R., Karabatsos, N., and Cropp, C. B. (1998). Phylogeny of the genus Flavivirus. J Virol 72(1), 73-83.
Lei, H. Y., Yeh, T. M., Liu, H. S., Lin, Y. S., Chen, S. H., and Liu, C. C. (2001). Immunopathogenesis of dengue virus infection. J Biomed Sci 8(5), 377-88.
Lin, Y. L., Lei, H. Y., Lin, Y. S., Yeh, T. M., Chen, S. H., and Liu, H. S. (2002). Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res 56(1), 93-6.
Lindenbach, B. D., and Rice, C. M. (2001). Flaviviridae: The viruses and their replication. 4th ed. In "Fields Virology" (D. M. Knipe, and P. M. Howley, Eds.), Vol. 1, pp. 991-1041. Lippincott-Williams & Wilkins, Philadelphia, Pa., USA.
Mukhopadhyay, S., Kuhn, R. J., and Rossmann, M. G. (2005). A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3(1), 13-22.
Murgue, B., Roche, C., Chungue, E., and Deparis, X. (2000). Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 60(4), 432-8.
Pujol, C. A., Scolaro, L. A., Ciancia, M., Matulewicz, M. C., Cerezo, A. S., and Damonte, E. B. (2006). Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection. Planta Med 72(2), 121-5.
Raghavendran, H. R., Sathivel, A., and Devaki, T. (2005). Effect of Sargassum polycystum (Phaeophyceae)-sulphated polysaccharide extract against acetaminophen-induced hyperlipidemia during toxic hepatitis in experimental rats. Mol Cell Biochem 276(1-2), 89-96.
Su, C. M., Liao, C. L., Lee, Y. L., and Lin, Y. L. (2001). Highly sulfated forms of heparin sulfate are involved in japanese encephalitis virus infection. Virology 286(1), 206-15.
Talarico, L. B., Pujol, C. A., Zibetti, R. G., Faria, P. C., Noseda, M. D., Duarte, M. E., and Damonte, E. B. (2005). The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res 66(2-3), 103-10.
Talarico, L. B., Zibetti, R. G., Faria, P. C., Scolaro, L. A., Duarte, M. E., Noseda, M. D., Pujol, C. A., and Damonte, E. B. (2004). Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int J Biol Macromol 34(1-2), 63-71.
Witvrouw, M., and De Clercq, E. (1997). Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol 29(4), 497-511.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top